[The clinical value of quantification of glucocorticoid receptors in peripheral blood mononuclear cells in myasthenia gravis].
To evaluate the value of glucocorticoid receptor (GR) number in predicting the glucorticoid (GC) therapeutic efficacy. GR number in peripheral blood mononuclear cells (PBMC) from thirty patients with myasthenia gravis (MG) was measured with (3)H-dexamethansone (DEX) radio-ligand binding assay. The efficacy of GC treatment was assessed with relative clinical score one month and six months after the treatment. Twenty-four patients with MG were monitored for GR number at different time points after GC treatment. The pre-treatment GR number was positively correlated with relative clinical score one month and six months after the treatment (r = 0.916 and r = 0.891, P < 0.01, respectively). The higher the pre-treatment GR number, the higher the clinical relative score and the better the efficacy of GC treatment. After GC treatment, GR number had a tendency to decline gradually. Pre-treatment GR number can be used as an adjuvant parameter for predicting GC therapeutic efficacy. GC treatment down-regulates GR.